definiens: shall mean, with respect to a Licensed Product, Patent Rights Controlled by [COMPANY] at any time during the Term that solely claim ( a ) ( i ) an siRNA contained in such Licensed Product, which siR NA is Directed to a Collaboration Target, and pharmaceutical compositions thereof ; ( ii ) such Lice nsed Product or specific components thereof to the extent such components are unique to such Licensed Product ; ( iii ) methods of using the compositions described in clause ( i ) or ( ii ) above in the Field, or to be Directed to the Collaboration Target of s uch Licensed Product, or to inhibit expression of such Collaboration Target, and foreign equivalents of su ch method claims ; ( iv ) methods and compositions direct ed to the synthesis or analysis of the compositions described in clause ( i ) or ( ii ) ; or ( b ) [COMPANY] Col laboration IP that is applicable solely to such Lic ensed Product ; provided, however, that any such Patent Rights that include claims t hat are directed to subject matter applicable to [ * * * ] to siRNA or siRNA delive ry in general will not be considered [COMPANY] Product - Specific Patent Rights but will be consider ed [COMPANY] Core Technology Patent Rights